Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurgical Innovations Regulatory News (SUN)

Share Price Information for Surgical Innovations (SUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.50
Bid: 0.40
Ask: 0.60
Change: 0.00 (0.00%)
Spread: 0.20 (50.00%)
Open: 0.50
High: 0.50
Low: 0.50
Prev. Close: 0.50
SUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

25 Jun 2008 12:00

RNS Number : 5066X
Surgical Innovations Group PLC
25 June 2008
 



Press Release

25 June 2008

Surgical Innovations™ Group plc

("SI" or "the Group")

AGM Statement and Trading Update

Surgical Innovations™ Group plc (AIMSUN), the designer and manufacturer of innovative surgical devices, will be holding its Annual General Meeting today at 1:00pm in Leeds.

At the meeting Doug Liversidge, Non-Executive Chairman, will provide the following trading update: 

"2007 was a year in which we once again delivered improved levels of sales and pre-tax profits.

"To meet the anticipated worldwide growth in minimally invasive surgery and the increasing demand for our suite of obesity-related products, we made the strategic decision to invest in new facilities that have substantially increased our capacity. This relocationour first since trading began in 1992, is complete and has tripled our floor space, consolidating all our operations into one location in Leeds. The move and subsequent refit has, as expected, required significant capital expenditure and we look forward to the benefits that this will provide the Group in the future.

"YelloPort Plus, our advanced laparoscopic port access system, continues to be well received by surgeons in the US. A series of important evaluations by major surgical procedural tray supply companies is progressing. This should open important routes to the procurement decision-makers in hospital groups across the country.  As a result of this, we anticipate that sales for the year will be biased towards the second half, as occurred in 2007.

"Elsewhere we see good opportunities to establish ourselves within new and growing markets - in particular in Eastern Europe where closer integration with the EU has meant that trading conditions are becoming more favourable. Countries such as BulgariaHungary, PolandRomania and Slovakia are beginning to invest further in laparoscopic surgery and we are already receiving orders from those countries following successful trials.  YelloPort Plus is now established in Spain following trials and evaluations, in addition we are also focusing on growth within Scandinavia and other key territories.

"To ensure we maintain our competitive advantage we continue to invest in product development in conjunction with our end-users and partners. We have recruited new designers and engineers to ensure we can meet the demands of an ever changing market.   We will be launching new products later this year and we are also reviewing new technologies and product licences where we see synergies with our existing range.

"There are approximately 1.2 billion overweight people around the world according to the World Health Organisation and this offers us the opportunity to further develop our instrumentation targeted at operations for obesity."

- Ends -

For further information:

Surgical Innovations Group plc

Graham Bowland, Finance Director

Tel: +44 (0) 113 230 7597

graham.bowland@surginno.co.uk 

www.sigroupplc.com 

Hanson Westhouse Limited

Tim Feather / Matthew Johnson

Tel: +44 (0) 113 246 2611

tim.feather@hansonwesthouse.com

www.hansonwesthouse.com 

Media enquiries:

Abchurch Communications

Sarah Hollins / Gareth Mead

Tel: +44 (0) 20 7398 7780

gareth.mead@abchurch-group.com

www.abchurch-group.com 

Notes to Editors:

Surgical Innovations Group plc specialises in the design and manufacture of innovative devices for use in minimally invasive surgery and industrial markets. The Group employs over 50 people and is headquartered in Leeds.

The Group's subsidiaries Surgical Innovations Limited and Haemocell Limited are focused on strong international growth in two specialist areas namely minimally invasive surgery, where products are used in 'keyhole' surgery which is more accurately known as laparoscopic surgery, and products for autologous blood transfusion whereby a patient's own blood is recycled.

The Group's subsidiary company Core Precision Limited utilises Surgical Innovations' core medical device design expertise and technology in innovative engineering applications.

For more information, see www.sigroupplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGMSEDFSISASEIM
Date   Source Headline
22nd Apr 20243:34 pmRNSHolding(s) in Company
19th Apr 20246:25 pmRNSHolding(s) in Company
18th Apr 20247:01 amRNSFinal Results
18th Apr 20247:00 amRNSNew exclusive UK distribution agreements secured
9th Apr 20247:00 amRNSDirectorate Change & Notice of Results
29th Jan 20247:00 amRNSYear-end 2023 Trading Update
19th Dec 20237:00 amRNSDirectorate Change
5th Dec 20237:00 amRNSDirectorate Change
19th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSTrading Update and Notice of Results
27th Jun 202312:12 pmRNSResult of AGM
27th Jun 20237:00 amRNSAGM Statement
26th May 20237:00 amRNSNotice of AGM and Posting of Annual Report
25th May 202311:11 amRNSDirector/PDMR Shareholding - Replacement
25th May 20237:00 amRNSDirector/PDMR Shareholding
22nd May 20237:00 amRNSDirectorate changes and board succession planning
29th Mar 20237:00 amRNSFinal Results
3rd Mar 20237:00 amRNSNotice of Results and Investor Presentation
23rd Jan 20237:00 amRNSYear-end Trading Update
21st Sep 20227:00 amRNSHalf-year Report
2nd Sep 20227:00 amRNSNotice of Interim Results
27th Jun 20223:15 pmRNSResult of AGM
27th Jun 20227:00 amRNSAGM Trading Statement
25th May 20227:00 amRNSPosting of 2021 Annual Report & Accounts
9th May 202212:41 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSFinal Results
21st Mar 20227:00 amRNSProduct launch in partnership with CMR Surgical
10th Mar 20227:00 amRNSNotice of Annual Results
17th Jan 20227:00 amRNSYear-end Trading Update
15th Nov 20217:00 amRNSChanges to Board Structure & CFO Appointment
10th Nov 20215:43 pmRNSGrant of Options
15th Sep 20217:00 amRNSHalf-year Report
27th Aug 20217:00 amRNSNotice of Interim Results
9th Jul 20212:29 pmRNSDirector/PDMR Shareholding
22nd Jun 20215:26 pmRNSResult of AGM
22nd Jun 20217:00 amRNSAGM Trading Statement
21st Jun 20217:00 amRNSWithdrawal of AGM Resolution
21st May 20217:00 amRNSPosting of Annual Report& Accounts & Notice of AGM
25th Mar 20217:00 amRNSFinal Results
22nd Mar 20217:00 amRNS3-year Exclusive UK distribution agreement
8th Mar 20217:00 amRNSNotice of annual results
15th Feb 20217:00 amRNS5-year USA distribution agreement
9th Feb 20217:00 amRNSLaunch of the Green Surgery Challenge
8th Jan 20217:00 amRNSDistalmotion’s Dexter Robot receives CE Mark
7th Jan 20217:00 amRNSFuture board change
21st Dec 20207:00 amRNSTrading update
17th Dec 20207:00 amRNSUS distribution agreement signed with Adler
7th Dec 20203:00 pmRNSReplacement of Auditor
2nd Dec 20207:00 amRNSProduct launch for Cellis Breast
25th Nov 20207:00 amRNSCentre for Sustainable Healthcare collaboration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.